163 related articles for article (PubMed ID: 31150631)
1. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats.
Miranda MLP; Furtado KS; de Oliveira Andrade F; Heidor R; da Cruz RS; Nogueira MS; de Castro IA; Purgatto E; Barbisan LF; Moreno FS
Chem Biol Interact; 2019 Aug; 308():377-384. PubMed ID: 31150631
[TBL] [Abstract][Full Text] [Related]
2. β-ionone modulates the expression of miRNAs and genes involved in the metastatic phenotype of microdissected persistent preneoplastic lesions in rats submitted to hepatocarcinogenesis.
Furtado KS; de Oliveira Andrade F; Campos A; Rosim MP; Vargas-Mendez E; Henriques A; De Conti A; Scolastici C; Barbisan LF; Carvalho RF; Moreno FS
Mol Carcinog; 2017 Jan; 56(1):184-196. PubMed ID: 27061051
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA.
Cardozo MT; de Conti A; Ong TP; Scolastici C; Purgatto E; Horst MA; Bassoli BK; Moreno FS
J Nutr Biochem; 2011 Feb; 22(2):130-5. PubMed ID: 20435455
[TBL] [Abstract][Full Text] [Related]
4. β-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-α, NF-κB, and p53 as cellular targets.
Scolastici C; de Conti A; Cardozo MT; Ong TP; Purgatto E; Horst MA; Heidor R; Furtado KS; Bassoli BK; Moreno FS
Nutr Cancer; 2014; 66(2):234-41. PubMed ID: 24364727
[TBL] [Abstract][Full Text] [Related]
5. The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.
Abd-Elbaset M; Mansour AM; Ahmed OM; Abo-Youssef AM
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1611-1624. PubMed ID: 32270258
[TBL] [Abstract][Full Text] [Related]
6. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
de Moura Espíndola R; Mazzantini RP; Ong TP; de Conti A; Heidor R; Moreno FS
Carcinogenesis; 2005 Jun; 26(6):1091-9. PubMed ID: 15718255
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
Nagahara T; Okano J; Fujise Y; Abe R; Murawaki Y
Biomed Pharmacother; 2010 May; 64(5):319-26. PubMed ID: 20434301
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis.
Toledo LP; Ong TP; Pinho AL; Jordão A; Vanucchi H; Moreno FS
Nutr Cancer; 2003; 47(1):62-9. PubMed ID: 14769539
[TBL] [Abstract][Full Text] [Related]
11. All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage.
de Almeida Vasconcelos Fonseca EM; Chagas CE; Mazzantini RP; Heidor R; Ong TP; Moreno FS
Carcinogenesis; 2005 Nov; 26(11):1940-6. PubMed ID: 15975960
[TBL] [Abstract][Full Text] [Related]
12. Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Cho Y; Kim BH; Park JW
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S220-S227. PubMed ID: 36353768
[TBL] [Abstract][Full Text] [Related]
13. Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis.
Romualdo GR; Silva EDA; Da Silva TC; Aloia TPA; Nogueira MS; De Castro IA; Vinken M; Barbisan LF; Cogliati B
Environ Toxicol; 2020 Apr; 35(4):518-527. PubMed ID: 31804025
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.
Ma C; Zhang Q; Greten TF
FEBS J; 2018 Feb; 285(4):752-762. PubMed ID: 28857485
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D
Goto RL; Tablas MB; Prata GB; Espírito Santo SG; Fernandes AAH; Cogliati B; Barbisan LF; Romualdo GR
J Steroid Biochem Mol Biol; 2022 Jan; 215():106022. PubMed ID: 34774723
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca.
Hussein UK; Mahmoud HM; Farrag AG; Bishayee A
Integr Cancer Ther; 2015 Nov; 14(6):525-45. PubMed ID: 26130745
[TBL] [Abstract][Full Text] [Related]
17. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
Nishimura N; Kaji K; Kitade M; Aihara Y; Sato S; Seki K; Sawada Y; Takaya H; Okura Y; Kawaratani H; Moriya K; Namisaki T; Mitoro A; Yoshiji H
BMC Cancer; 2018 Nov; 18(1):1164. PubMed ID: 30477453
[TBL] [Abstract][Full Text] [Related]
18. Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer.
Watanabe S; Kitade Y; Masaki T; Nishioka M; Satoh K; Nishino H
Nutr Cancer; 2001; 39(1):96-101. PubMed ID: 11588908
[TBL] [Abstract][Full Text] [Related]
19. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
Sagawa H; Naiki-Ito A; Kato H; Naiki T; Yamashita Y; Suzuki S; Sato S; Shiomi K; Kato A; Kuno T; Matsuo Y; Kimura M; Takeyama H; Takahashi S
Carcinogenesis; 2015 Dec; 36(12):1539-49. PubMed ID: 26494227
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
